DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that the CCGs (Clinical Commissioning Groups) in three UK regions have named the DarioTM Blood Glucose Monitoring System the first choice for all patients with type 1 diabetes, in the area of “Smart meters with Carb counting.”

Read more on Globe Newswire here.